Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
MRCS syndrome is a rare, genetic retinal dystrophy disorder characterized by bilateral microcornea, rod-cone dystrophy, cataracts and posterior staphyloma, in the absence of other systemic features. Night blindness is typically the presenting manifestation and nystagmus, strabismus, astigmatism and angle closure glaucoma may be associated findings. Progressive visual acuity deterioration, due to pulverulent-like cataracts, results in poor vision ranging from no light perception to 20/400.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for MRCS syndrome.
1 publication has been identified in PubMed for MRCS syndrome. Research spans Review / Meta-Analysis (100%).
Pagano L (2025). [PMID: 40347359](https://pubmed.ncbi.nlm.nih.gov/40347359/). *Drugs*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:00 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about MRCS syndrome